Option Care Health, Inc.
NASDAQ:OPCH · NASDAQ Global Select
+$0.45 today
Vol 3.56M · Avg 3.09M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
15.7%
avg 59.4%
ROIC
9.3%
avg -3.0%
ROA
6.0%
avg -4.3%
Analysis
ROE is currently the strongest return metric at 15.7% versus its period average of 59.4%. 2 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
John Charles Rademacher | Chief Executive Officer, President & Director | $2.77M | — | 59 | $695,152.00 | 0.44% |
Luke Whitworth | Chief Operating Officer | $1.31M | — | 45 | $169,589.00 | 0.11% |
Michael Bavaro | Chief Human Resources & Chief Diversity Officer | $981,869.00 | — | 48 | $33,249.00 | 0.02% |
Collin G. Smyser | General Counsel & Corporate Secretary | $977,320.00 | — | 47 | $75,372.00 | 0.05% |
Meenal Anil Sethna | Executive Vice President & Chief Financial Officer | $809,119.00 | — | 56 | $98,337.00 | 0.06% |
Christopher L. Grashoff | Chief Growth Officer | $784,666.00 | — | 46 | $24,498.00 | 0.02% |
Brett Michalak | Chief Technology Officer | — | — | — | — | — |
Nicole Maggio | Senior Vice President, Controller & Principal Accounting Officer | — | — | 43 | $28,489.00 | 0.02% |
Stacey Mahone | Senior Vice President & Chief Compliance Officer | — | — | — | — | — |
Jorge Ramirez | Senior Vice President of Strategy and Corporate Development | — | — | — | — | — |
Julie Koenig | Senior Vice President of Operations | — | — | — | — | — |
Alyssa Moy | Chief Information Officer | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
10
$4.54M
Sells
2
$1.17M
Net Sentiment
+$3.37M
Net buying
Most Active
KRAEMER HARRY M JANSEN JR
3 transactions
1–10 of 12
Analysis
Insiders reported 10 buys worth $4.54M and 2 sells worth $1.17M over the last 12 months. That adds up to net buying of $3.37M. KRAEMER HARRY M JANSEN JR was the most active insider with 3 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +18.3% | +14.7% (15yr)7 analysts |
| Net Income | N/A | N/A | N/A | N/A7 analysts |
| EBIT | N/A | N/A | N/A | N/A7 analysts |
Analysis
Recent growth has been strongest in Revenue at +18.3% over three years. Forward estimates point to Revenue at +14.7% (15yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Kymera Therapeutics, Inc.
NASDAQ:KYMR
$7.48B
Oscar Health, Inc.
NYSE:OSCR
$7.34B
Immunovant, Inc.
NASDAQ:IMVT
$7.18B
Lantheus Holdings, Inc.
NASDAQ:LNTH
$6.77B
Hinge Health, Inc.
NYSE:HNGE
$5.21B
Indivior Pharmaceuticals Inc
NASDAQ:INDV
$4.76B
Akero Therapeutics, Inc.
AKRO
$4.50B
ACADIA Pharmaceuticals Inc.
NASDAQ:ACAD
$3.67B
TransMedics Group, Inc.
NASDAQ:TMDX
$2.70B
ADMA Biologics, Inc.
NASDAQ:ADMA
$1.96B
Who manages OPCH?
Option Care Health, Inc. (OPCH) lists 12 active executives. The top listed executive is Brett Michalak, Chief Technology Officer.
Are OPCH insiders buying or selling?
Recent insider activity shows net selling of $18.44M.
Explore More
Continue the stock analysis
Jump to another research area for this company.